{
  "feed_type": "scraper_specific",
  "scraper_name": "fda_scraper",
  "website": "fda.gov",
  "generated_at": "2025-11-19T14:29:12.275923",
  "total_items": 50,
  "max_items": 50,
  "items": [
    {
      "id": "ffa41782-4fbd-4e33-97b0-031f868d99b6",
      "title": "FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-responds-evidence-possible-association-between-autism-and-acetaminophen-use-during-pregnancy",
      "date": "2025-09-22",
      "category": "General",
      "excerpt": "FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:14:43.125430"
    },
    {
      "id": "34919ae6-ea7f-43f2-a70e-c3541ee57faa",
      "title": "FDA Takes Action to Make a Treatment Available for Autism Symptoms",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-takes-action-make-treatment-available-autism-symptoms",
      "date": "2025-09-22",
      "category": "General",
      "excerpt": "FDA Takes Action to Make a Treatment Available for Autism Symptoms",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:14:43.125430"
    },
    {
      "id": "1c71b390-0ae8-4ec6-b9da-cc12e50872bb",
      "title": "FDA Grants Accelerated Approval to First Treatment for Barth Syndrome",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome",
      "date": "2025-09-19",
      "category": "General",
      "excerpt": "FDA Grants Accelerated Approval to First Treatment for Barth Syndrome",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:14:43.125430"
    },
    {
      "id": "5f0ae127-febc-4192-b19f-b106dea92b78",
      "title": "FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-launches-real-time-adverse-event-reporting-dashboard-cosmetic-products",
      "date": "2025-09-12",
      "category": "General",
      "excerpt": "FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "7a58dae5-28e1-4c40-b91c-b4ad61d91c25",
      "title": "HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-cbp-seize-865-million-worth-illegal-e-cigarettes-largest-ever-operation",
      "date": "2025-09-10",
      "category": "Tobacco Products",
      "excerpt": "HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "4d74b92f-5a92-43a9-9983-cb87057b2015",
      "title": "FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-issues-new-guidance-expand-non-opioid-options-chronic-pain-curb-misuse",
      "date": "2025-09-10",
      "category": "General",
      "excerpt": "FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "5d6007e8-b67e-47d1-a78b-3ad565e82a34",
      "title": "FDA Launches Crackdown on Deceptive Drug Advertising",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising",
      "date": "2025-09-09",
      "category": "Drug Safety",
      "excerpt": "FDA Launches Crackdown on Deceptive Drug Advertising",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "7891fd98-2b27-4d7b-89ff-3da96ee4b050",
      "title": "FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-vonvendi-von-willebrand-disease-including-certain-uses-children",
      "date": "2025-09-05",
      "category": "General",
      "excerpt": "FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "f28b2749-7835-4d69-8f4e-8c90b6f4cae7",
      "title": "FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients",
      "date": "2025-09-05",
      "category": "Drug Safety",
      "excerpt": "FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "04285587-0d25-4e00-85b7-ee18d2bc936e",
      "title": "FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-announces-real-time-release-complete-response-letters-posts-previously-unpublished-batch-89",
      "date": "2025-09-04",
      "category": "General",
      "excerpt": "FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "7e7277c1-f9c7-4aa5-b67c-8d6c6e3d96bd",
      "title": "FDA Advances Rare Disease Drug Development with New Evidence Principles",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-advances-rare-disease-drug-development-new-evidence-principles",
      "date": "2025-09-03",
      "category": "Drug Safety",
      "excerpt": "FDA Advances Rare Disease Drug Development with New Evidence Principles",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "59cadf53-85c2-4386-b24f-b829cd704f8e",
      "title": "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-urges-nicotine-pouch-manufacturers-use-child-resistant-packaging-following-increasing-reports",
      "date": "2025-09-02",
      "category": "General",
      "excerpt": "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:13:36.435532"
    },
    {
      "id": "942dcca1-9105-4a0c-9231-43e242e9bcf5",
      "title": "FDA Begins Real-Time Reporting of Adverse Event Data",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-begins-real-time-reporting-adverse-event-data",
      "date": "2025-08-22",
      "category": "General",
      "excerpt": "FDA Begins Real-Time Reporting of Adverse Event Data",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "7851ebcd-b0fe-4b71-85d9-315f0166db3b",
      "title": "HHS Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm, Protect U.S. Food Supply",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-allows-fda-emergency-use-animal-drugs-combat-new-world-screwworm-protect-us-food-supply",
      "date": "2025-08-19",
      "category": "Drug Safety",
      "excerpt": "HHS Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm, Protect U.S. Food Supply",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "fad9b7c5-b5db-4312-8bf6-8663b38c7cdb",
      "title": "FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-immunotherapy-recurrent-respiratory-papillomatosis",
      "date": "2025-08-14",
      "category": "General",
      "excerpt": "FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "a411f992-dbf8-47c2-855d-eb43029bdd9c",
      "title": "Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products",
      "url": "https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-marty-makary-md-mph-florida-restriction-7-oh-opioid-products",
      "date": "2025-08-13",
      "category": "General",
      "excerpt": "Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "f7eb42a8-2afb-4974-8957-00747e9251be",
      "title": "FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-commissioner-makary-usda-secretary-rollins-celebrate-proposed-modernization-orange-juice",
      "date": "2025-08-08",
      "category": "General",
      "excerpt": "FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "c5494154-f61c-46e7-be99-84566f515d86",
      "title": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H.: Announcing Resolution of the IV Saline Solutions Shortage",
      "url": "https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-marty-makary-md-mph-announcing-resolution-iv-saline-solutions-shortage",
      "date": "2025-08-08",
      "category": "General",
      "excerpt": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H.: Announcing Resolution of the IV Saline Solutions Shortage",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "110a4207-d1b0-46ba-940e-cbdd07d71419",
      "title": "FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-announces-new-fda-precheck-program-boost-us-drug-manufacturing",
      "date": "2025-08-07",
      "category": "Drug Safety",
      "excerpt": "FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "32df2e53-3adf-4288-ba68-2a13bf114226",
      "title": "FDA Names Top HHS Lawyer as Chief Counsel",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel",
      "date": "2025-08-04",
      "category": "General",
      "excerpt": "FDA Names Top HHS Lawyer as Chief Counsel",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "fd934577-f020-48ae-aafa-78e40a7751d0",
      "title": "FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks",
      "date": "2025-07-31",
      "category": "Drug Safety",
      "excerpt": "FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "ddfba22d-3783-4253-8fb9-d8f500838f98",
      "title": "FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers",
      "date": "2025-07-29",
      "category": "General",
      "excerpt": "FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "838edffd-6bed-493d-b179-85ca1b4a5a94",
      "title": "FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-recommends-removal-voluntary-hold-elevidys-ambulatory-patients",
      "date": "2025-07-28",
      "category": "General",
      "excerpt": "FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "27e3f28e-e3a8-49d9-8ed5-580272f3d0ca",
      "title": "FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-investigating-death-8-year-old-boy-who-received-elevidys",
      "date": "2025-07-25",
      "category": "General",
      "excerpt": "FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "5661de1b-765d-4533-9b81-39d37674430c",
      "title": "HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-fda-and-usda-address-health-risks-ultra-processed-foods",
      "date": "2025-07-23",
      "category": "Food Safety",
      "excerpt": "HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "a4022fd4-4ea5-4b75-ad63-4abd33020db3",
      "title": "HHS, FDA Praise Consumer Brands Association’s Vow to Remove Artificial Colors from America’s Food Supply",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-fda-praise-consumer-brands-associations-vow-remove-artificial-colors-americas-food-supply",
      "date": "2025-07-22",
      "category": "Food Safety",
      "excerpt": "HHS, FDA Praise Consumer Brands Association’s Vow to Remove Artificial Colors from America’s Food Supply",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "9a660912-47de-4558-8a68-d342053e4237",
      "title": "Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research",
      "url": "https://www.fda.gov/news-events/press-announcements/stanford-faculty-member-george-tidmarsh-md-phd-named-director-center-drug-evaluation-and-research",
      "date": "2025-07-21",
      "category": "Drug Safety",
      "excerpt": "Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "df00c88c-1e3f-474a-a5f2-74f01fe6984b",
      "title": "FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-requests-sarepta-therapeutics-suspend-distribution-elevidys-and-places-clinical-trials-hold",
      "date": "2025-07-18",
      "category": "General",
      "excerpt": "FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "8d50c6cb-0814-4a19-b9d5-e2f3d5d4dee8",
      "title": "FDA to Revoke 52 Obsolete Standards of Identity for Food Products",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-revoke-52-obsolete-standards-identity-food-products",
      "date": "2025-07-16",
      "category": "Food Safety",
      "excerpt": "FDA to Revoke 52 Obsolete Standards of Identity for Food Products",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "90b27e6c-cc1a-47a5-9045-01eeb92d5080",
      "title": "FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-firms-marketing-products-containing-7-hydroxymitragynine",
      "date": "2025-07-15",
      "category": "General",
      "excerpt": "FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "a458d217-1e2f-45d3-9bbe-aa960ce7267f",
      "title": "FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-gardenia-genipin-blue-color-additive-while-encouraging-faster-phase-out-fdc-red-no-3",
      "date": "2025-07-14",
      "category": "General",
      "excerpt": "FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "48624c1a-fcae-4d15-b082-9efb76d9a0f7",
      "title": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H:  100 Days of Embracing Gold-Standard Science, Transparency and Common Sense",
      "url": "https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-marty-makary-md-mph-100-days-embracing-gold-standard-science-transparency",
      "date": "2025-07-10",
      "category": "General",
      "excerpt": "A Statement from FDA Commissioner Marty Makary, M.D., M.P.H:  100 Days of Embracing Gold-Standard Science, Transparency and Common Sense",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "853efb5d-655f-4b59-a18f-690ff2be4d7f",
      "title": "FDA Embraces Radical Transparency by Publishing Complete Response Letters",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-embraces-radical-transparency-publishing-complete-response-letters",
      "date": "2025-07-10",
      "category": "General",
      "excerpt": "FDA Embraces Radical Transparency by Publishing Complete Response Letters",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "5d7fb8ec-c31b-4ef4-99e4-e55e1496e5c0",
      "title": "FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-encourages-industry-leaders-streamline-enhance-product-recall-communications-safeguard-foods",
      "date": "2025-07-09",
      "category": "Food Safety",
      "excerpt": "FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "d247f4d5-484b-4147-9b97-cb66c3c3d0be",
      "title": "FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor",
      "date": "2025-06-27",
      "category": "General",
      "excerpt": "FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "cfa3874a-0ca3-409e-b5a8-9099c1607282",
      "title": "FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-halts-new-clinical-trials-export-americans-cells-foreign-labs-hostile-countries-genetic",
      "date": "2025-06-18",
      "category": "General",
      "excerpt": "FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "5e442282-49f3-4055-ad47-a1285986c39a",
      "title": "FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests",
      "date": "2025-06-17",
      "category": "General",
      "excerpt": "FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "46ac9e85-8d20-4d92-9c36-102331842f10",
      "title": "FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-launches-agency-wide-ai-tool-optimize-performance-american-people",
      "date": "2025-06-02",
      "category": "General",
      "excerpt": "FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "7b6fbf59-daaa-4eb9-8e97-7673fdace786",
      "title": "FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-takes-action-address-data-integrity-concerns-two-chinese-third-party-testing-firms",
      "date": "2025-05-22",
      "category": "General",
      "excerpt": "FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "09c287d1-585f-44a3-a41f-6e2f037edcda",
      "title": "FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-and-cbp-seize-nearly-34-million-worth-illegal-e-cigarettes-during-joint-operation",
      "date": "2025-05-22",
      "category": "Tobacco Products",
      "excerpt": "FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "7cbccf77-09fa-4abd-bab7-05465197926f",
      "title": "FDA takes steps to enhance state importation programs to help lower prescription drug prices",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-takes-steps-enhance-state-importation-programs-help-lower-prescription-drug-prices",
      "date": "2025-05-21",
      "category": "Drug Safety",
      "excerpt": "FDA takes steps to enhance state importation programs to help lower prescription drug prices",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "9a944165-1165-4640-adf9-7e6b9e599498",
      "title": "FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease",
      "date": "2025-05-16",
      "category": "General",
      "excerpt": "FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "88eb9e82-f06f-42f8-b3a6-82b3896689b3",
      "title": "FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-host-inaugural-independent-scientific-expert-panel-open-public",
      "date": "2025-05-16",
      "category": "General",
      "excerpt": "FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "a91e5649-43cd-4fd9-83cb-d29a8a9db5e3",
      "title": "FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-advances-robust-transparent-post-market-chemical-review-program-keep-food-supply-safe-and",
      "date": "2025-05-15",
      "category": "Food Safety",
      "excerpt": "FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "46aa5e59-26f8-4f47-b202-9743cd0266c3",
      "title": "FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-begins-action-remove-ingestible-fluoride-prescription-drug-products-children-market",
      "date": "2025-05-13",
      "category": "Drug Safety",
      "excerpt": "FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "d843a46d-b1ea-4b56-9795-33a5b009b3e2",
      "title": "HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-fda-initiate-comprehensive-review-nutrients-infant-formula",
      "date": "2025-05-13",
      "category": "General",
      "excerpt": "HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "0779db6b-5dd6-40e9-bdf3-2d02daa16eed",
      "title": "HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers",
      "url": "https://www.fda.gov/news-events/press-announcements/hhs-fda-issue-rfi-deregulatory-plan-lower-costs-and-empower-providers",
      "date": "2025-05-13",
      "category": "General",
      "excerpt": "HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "bfb1169b-7674-4a66-947a-db4168892789",
      "title": "FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-and-nih-announce-innovative-joint-nutrition-regulatory-science-program",
      "date": "2025-05-09",
      "category": "General",
      "excerpt": "FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "5561f781-530a-4308-ace6-908664b7174e",
      "title": "FDA Approves Three Food Colors from Natural Sources",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-approves-three-food-colors-natural-sources",
      "date": "2025-05-09",
      "category": "Food Safety",
      "excerpt": "FDA Approves Three Food Colors from Natural Sources",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    },
    {
      "id": "f5fb50ad-2818-4e40-8e1e-b4b94c237c6d",
      "title": "FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline",
      "url": "https://www.fda.gov/news-events/press-announcements/fda-announces-completion-first-ai-assisted-scientific-review-pilot-and-aggressive-agency-wide-ai",
      "date": "2025-05-08",
      "category": "General",
      "excerpt": "FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline",
      "source_website": "fda.gov",
      "scraped_at": "2025-09-25T03:15:36.796824"
    }
  ]
}